News COVID-19 Vaccine Does Not Increase CV Event Risk in Those With Existing Disease Publish Date June 27, 2022
News USPSTF Recommends Against Vitamin E, Beta-Carotene Use for CVD and Cancer Prevention By Brian Park, PharmD Publish Date June 22, 2022
Drugs in the Pipeline Eplontersen Bests Placebo in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Study By Brian Park, PharmD Publish Date June 21, 2022
Drugs in the Pipeline New Data Prompt FDA Review Period Extension for Omecamtiv Mecarbil By Brian Park, PharmD Publish Date June 21, 2022
News Amvuttra Approved for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis By Brian Park, PharmD Publish Date June 14, 2022
News ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk Publish Date June 7, 2022
News Heart Failure Hospitalization Risk Compared With Empagliflozin vs Other Glucose-Lowering Txs By Brian Park, PharmD Publish Date June 6, 2022
Drugs in the Pipeline NDA Submitted for Landiolol, a Highly Cardioselective Beta Blocker By Brian Park, PharmD Publish Date June 2, 2022
News No Increase in Long-Term Mortality Seen With Peripheral Drug-Coated Devices Publish Date June 2, 2022
News Aspirin May Lower Cardiovascular Risks in Chronic Kidney Disease Population By Jody A. Charnow Publish Date May 27, 2022
News Dry Powder Inhaler Containing Treprostinil Gets FDA Approval By Diana Ernst, RPh Publish Date May 25, 2022
News Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D Publish Date May 25, 2022
Drugs in the Pipeline Aprocitentan Significantly Reduces BP in Patients With Resistant Hypertension By Brian Park, PharmD Publish Date May 24, 2022